Patti Oto, R.Ph.

Senior Vice President of Regulatory Affairs and Quality Assurance

Patti Oto has over 25 years of executive leadership experience with regulatory and quality oversight. Prior to joining Chrono Therapeutics, Patti was at Incline Therapeutics (acquired by The Medicines Company) where she served as the Vice President of Global Regulatory and Quality, managing the regulatory and quality activities for the analgesia pipeline. Previous to Incline, Patti worked in roles of increasing responsibilities in quality and regulatory at Onyx Pharmaceuticals (Amgen), Corgentech (Anesiva), Coulter (Corixa, GlaxoSmithKline), Genentech (Roche), and Syntex. Patti has worked on global regulatory submissions in support of marketing authorizations for biologics, drugs and drug/device combination products in several therapeutic areas including cardiovascular, metabolics, oncology and pain management. 

Patti is a registered pharmacist and received her B.S. in Pharmacy from the University of New Mexico.